Skip to content

"Drug utilization study of anti-diabetic drugs"

Retrospective, Pharmacoepidemiological Study of Prescription and utilization pattern of anti-diabetic drugs and variation in prescription pattern in relation with age and comorbidities in type-2 diabetic patients of tertiary care hospital.

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2013/07/003839
Enrollment
669
Registered
2013-07-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Type 2 Diabetes Mellites

Interventions

None listed

Sponsors

Dr Mirza Shiraz Baig
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Records of Type-2 DM patients treated in Govt. Medical College, Aurangabad, from January to December 2010 were collected from medical records section. Anti-diabetic drugs, biguanides (metformin) sulphonylureas (glibenclamide) and other anti-diabetic drugs (insulin) commonly prescribed in diabetes management were studied and also its influence on age and co-morbidities were studied.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
To study prescription and utilization pattern of anti-diabetic drugsTimepoint: 1 year

Secondary

MeasureTime frame
To evaluate the influence of age and co-morbidities on prescription.Timepoint: 1 year

Countries

India

Contacts

Public ContactDr Sachin D Shende

Dept. of Pharmacology, GMC, Aurangabad.

shirazdoctor@yahoo.com919823078631

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026